New 2025 Maryland Health Care Laws

The Maryland General Assembly’s 2025 legislative Session concluded with the enactment of many health care laws that will impact health care facilities, providers, insurers, and patients in the State. Here are some of the highlights from the 2025 Session. Artificial Intelligence  A new law was enacted concerning the use of Artificial Intelligence (AI) by certain…Read More

Where Do You Get Your Ozempic?

Ozempic® is the band name of one of the increasingly available glucagon-like peptide-1 (GLP-1) receptor agonists, created to treat Type 2 diabetes but increasingly used to promote extreme weight loss. GLP-1s include semaglutide (brand names Ozempic®, Wegovy®, and Rybelsus®) and tirzepatide (brand names Monjaro® and Zepbound®), two drugs that, until recently, were on the Food…Read More

Ambient Scribes

The explosive growth of artificial intelligence (AI) offers many opportunities to increase efficiency in health care delivery, allowing providers to focus more of their time on delivering quality care, but providers must thoughtfully navigate long standing privacy laws when deploying new technology. An increasingly common application of AI in the health care space is ambient…Read More

Changes in Premerger Notification

On November 12, 2024, the Federal Trade Commission (FTC) issued a new final rule on “Premerger Notification; Reporting and Waiting Period Requirement”. This rule (the New Rule) addresses areas the FTC identified as deficiencies under the current implementation of the Hart-Scott-Rodino Improvements Act of 1976 (HSR). HSR obligates premerger reporting requirements for parties in certain…Read More